Adaptive Biotechnologies Corporation, a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose...
Endologix LLC, a privately held, global medical device company dedicated to providing disruptive therapies for the interventional treatment of vascular disease, announces that the...
Cyclo Therapeutics, Inc, a clinical stage biotechnology company focused on developing transformative therapies for rare and neurological diseases with limited treatment options, and Applied Molecular...
Fluent, the premier dental insights company delivering customized, actionable business intelligence to support a variety of dental stakeholder objectives, announced that Sean Carroll has been...
Elligo Health Research, the largest healthcare-enabling research organization, announced that Elligo’s Founder and CEO, John Potthoff, Ph.D., transitioned his leadership to COO, Barry Simms. Potthoff...
